Teaching Doctors in Training to Reason With Artificial Intelligence (TEACH-AI)
Teaching Internal Medicine and Family Medicine Residents to Reason With Generative AI: A Multi-Site Randomized Controlled Trial (TEACH-AI)
The purpose of the TEACH-AI study is to assess whether a brief, structured workshop on artificial intelligence can improve the performance of medicine doctors in training (i.e. residents) in their diagnostic and management reasoning.
In this multi-site randomized controlled trial, internal medicine and family medicine residents are assigned either to receive an in-person workshop on safe, effective LLM use before a standardized AI-assisted assessment, or to complete the same assessment before receiving the workshop. Residents will review clinical cases that are fully synthetic, no protected health information is used, using a password protected LLM interface.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
Large language models (LLMs) have rapidly entered routine use in medical education and clinical practice. Prior randomized trials have shown that, although LLMs can outperform individual clinicians on some reasoning benchmarks, providing physicians with access to an LLM does not necessarily improve their diagnostic or management performance, and LLMs alone may perform better than physician-plus-LLM teams. These findings suggest that human-AI collaboration is fraught, non-trivial and may require explicit training.
TEACH-AI is a pragmatic, multi-site, two-arm randomized controlled trial embedded within protected residency didactic time. The primary objective is to determine whether a single in-person workshop on the basics of LLMs and best practices of prompting/verification strategies improves residents' performance on an AI-assisted assessment, compared with residents who complete the simulation before receiving the workshop. All participants will ultimately receive the same workshop and the same assessment (either workshop-first vs assessment-first).
The simulation consists of multiple fully synthetic vignettes delivered via a password protected LLM interface. Residents interact freely with the LLM using natural-language prompts and then submit structured final responses regarding aspects such as leading diagnosis, differential, management plan, and/or justification. The platform will record prompts, model outputs, final answers, and timing. Vignette scoring combines correctness of the final diagnosis or management plan. Scoring is conducted by blinded faculty using standardized rubrics and then any discrepancies will be resolved through multiple rounds of discussions.
The trial will enroll up to 200 residents across four ACGME-accredited programs (internal medicine at Beth Israel Deaconess Medical Center, Stanford University, and Cambridge Health Alliance; family medicine at AdventHealth Orlando).
Tipo di studio
Iscrizione (Stimato)
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
- Nome: Jacob M Koshy, MD, MPH
- Numero di telefono: 617-754-4677
- Email: jkoshy@bidmc.harvard.edu
Luoghi di studio
-
-
California
-
Palo Alto, California, Stati Uniti, 94305
- Stanford University
-
Contatto:
- Kevin Keet, MD
- Numero di telefono: 650-498-4559
- Email: kkeet@stanford.edu
-
Investigatore principale:
- Kevin R Keet, MD
-
-
Florida
-
Orlando, Florida, Stati Uniti, 32804
- AdventHealth
-
Contatto:
- Raj Mehta, MD
- Numero di telefono: 407-845-8383
- Email: raj.mehta.md@adventhealth.com
-
Investigatore principale:
- Raj Mehta, MD
-
-
Massachusetts
-
Boston, Massachusetts, Stati Uniti, 02215
- Beth Israel Deaconess Medical Center
-
Contatto:
- Jacob M Koshy, MD, MPH
- Numero di telefono: 617-754-4677
- Email: jkoshy@bidmc.harvard.edu
-
Investigatore principale:
- Jacob M Koshy, MD, MPH
-
Cambridge, Massachusetts, Stati Uniti, 02139
- Cambridge Health Alliance
-
Contatto:
- Priyank Jain, MD
- Numero di telefono: 617-665-1000
-
Investigatore principale:
- Priyank Jain, MD
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Bambino
- Adulto
- Adulto più anziano
Accetta volontari sani
Descrizione
Inclusion Criteria:
- Participants must be licensed physicians and have started at least post-graduate year 1 (PGY1) of medical training.
- Training in Internal medicine or family medicine or emergency medicine.
- Able to provide informed consent and complete assessments in English.
Exclusion Criteria:
- Not currently practicing clinically.
- Resident directly involved in the design of the study, development of the workshop, or creation/piloting of the assessment vignettes.
- Resident who declines or withdraws consent.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Diagnostico
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Separare
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Nessun intervento: Assessment-First
Participants assigned to this group will be tasked with completing the assessment using a password protected LLM interface first in advance of the workshop.
The workshop will be delivered during a scheduled mandatory didactic time slot.
|
|
|
Sperimentale: Workshop-first
Participants assigned to this group will be tasked with completing the assessment using a password protected LLM interface after they participate in a scheduled mandatory didactic time slot.
|
Participants will attend a workshop during their didactic time that will review various aspects of large language models including fundamentals and best practices of interacting and interpreting their outputs.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Total Score on Expert-Development Rubrics
Lasso di tempo: Within 24 hours of assessment completion.
|
The primary outcome will be the number of correct responses for all cases using select questions from expert-developed scoring rubrics.
The rubrics were developed using a Delphi consensus process by expert physicians as established by Goh et al (Nature Medicine, 2025; DOI: 10.1038/s41591-024-03456-y). The primary outcome will be analyzed at the case level, comparing performance between the randomized study groups, with a higher number of correct responses indicating a better outcome.
|
Within 24 hours of assessment completion.
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Time Spent on Management
Lasso di tempo: Within 24 hours of assessment completion.
|
Comparison of time spent per case between the two study groups.
|
Within 24 hours of assessment completion.
|
|
Prompt Count
Lasso di tempo: Within 24 hours of assessment completion.
|
Comparison of the number of resident-initiated prompts to the LLM per case between the two study groups.
|
Within 24 hours of assessment completion.
|
|
Management Reasoning Using Expert-Derived Rubrics
Lasso di tempo: Within 24 hours of assessment completion.
|
Comparison of management reasoning accuracy based on the number of correct responses per case between the two groups on expert-developed scoring rubrics.
The rubrics were developed using a Delphi consensus process by expert physicians as established by Goh et al (Nature Medicine, 2025; DOI: 10.1038/s41591-024-03456-y). The primary outcome will be analyzed at the case level, comparing performance between the randomized study groups with more correct responses indicating a better outcome.
|
Within 24 hours of assessment completion.
|
|
Diagnostic Reasoning
Lasso di tempo: Within 24 hours of assessment completion.
|
Comparison of diagnostic reasoning accuracy based on the number of correct responses per case between the two groups.
|
Within 24 hours of assessment completion.
|
Collaboratori e investigatori
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Altri numeri di identificazione dello studio
- 2026P000369
- 63901784-350738 (Altro numero di sovvenzione/finanziamento: Macy Foundation)
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .